Related Experiment Video
Updated: Jan 21, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
The del Nido versus cold blood cardioplegia in aortic valve replacement: A randomized trial
Krzysztof Sanetra1, Witold Gerber1, Rajesh Shrestha1
11st Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland; Center for Cardiovascular Research and Development, American Heart of Poland, Bielsko-Biała, Poland.
Insights
The del Nido (DN) cardioplegia protocol, requiring a single infusion, showed a significant reduction in ventricular fibrillation during reperfusion compared to cold blood (CB) cardioplegia in aortic valve replacement patients. DN cardioplegia is a viable alternative for cardiac protection.
Area of Science:
- Cardiovascular Surgery
- Cardiac Anesthesia
- Cardioprotection
Background:
- Aortic valve replacement (AVR) necessitates effective myocardial protection strategies.
- Traditional cold blood (CB) cardioplegia requires multiple infusions during ischemic durations.
- The del Nido (DN) cardioplegia solution offers a single-infusion approach for potential improved cardioprotection.
Purpose of the Study:
- To compare the cardioprotective efficacy of single-infusion del Nido (DN) cardioplegia versus multi-infusion cold blood (CB) cardioplegia.
- To evaluate primary endpoints including electrical cardiac activity, ventricular fibrillation, and myocardial injury markers (troponin, CK-MB).
Main Methods:
- A randomized trial involving 150 patients undergoing AVR.
- Patients were assigned to either the del Nido (DN) cardioplegia group (infusion every 90 minutes) or the cold blood (CB) cardioplegia group (infusion every 20-30 minutes or upon observed cardiac activity).
- Primary endpoints assessed were intraoperative electrical activity, post-reperfusion ventricular fibrillation, and postoperative cardiac enzyme levels at 24 and 48 hours.
Main Results:
- No significant difference in electrical cardiac activity during crossclamp between DN and CB groups (39.7% vs 45.3%, P=1.0).
- Significantly lower incidence of ventricular fibrillation post-reperfusion in the DN group (22.7%) compared to the CB group (54.7%, P=.001).
- Trend towards lower postoperative troponin and CK-MB levels in the DN group, although not statistically significant.
Conclusions:
- The del Nido cardioplegia protocol is a safe and effective alternative to cold blood cardioplegia for patients undergoing aortic valve replacement.
- DN cardioplegia demonstrates a significant advantage in reducing ventricular fibrillation during the critical reperfusion phase.
Objectives:
To compare the cardioprotective efficacy of a solution that requires only a single infusion at the start of the ischemic duration versus a solution that requires multiple infusions.
Methods:
Aortic valve replacement was performed for 150 patients, who were randomized into the del Nido (DN) cardioplegia group or the cold blood (CB) cardioplegia group. The DN cardioplegia was delivered every 90 minutes and the CB cardioplegia was delivered every 20 to 30 minutes, or whenever cardiac activity was observed. The primary endpoints were electrical cardiac activity during crossclamp, ventricular fibrillation during reperfusion, and postoperative troponin and creatine kinase (CK-MB isoenzyme) at 24 and 48 hours.
Results:
Electrical activity during crossclamp occurred in 29 (39.7%) patients in the DN group versus 34 (45.3%) patients in the CB group (adjusted P = 1.0). The number of procedures with ventricular fibrillation after removing the crossclamp was 41 (54.7%) in the CB group versus 17 (22.7%) in the DN group (adjusted P = .001; relative risk, 2.41). Troponin values appeared to be lower in the DN group (median, 223.10; interquartile range, 168.35-364.77 pg/mL vs 285.5; 196.20-419.45 pg/mL at 24 hours and 159.60; 125.42-217.20 pg/mL vs 201.60; 160.62-268.45 pg/mL at 48 hours) and CK-MB (median, 14.94; interquartile range, 12.16-20.39 ng/mL vs 17.43; 13.66-22.43 ng/mL at 24 hours and 6.19; 4.41-7.63 ng/mL vs 7.38; 4.74-10.20 ng/mL at 48 hours), but no significance was found.
Conclusions:
The del Nido cardioplegia protocol is an acceptable alternative for cold blood cardioplegia in patients undergoing aortic valve replacement.
Related Concept Videos
Gradient and Del Operator
Clinical Trials
There are four phases in a clinical trial. A phase one...
Responses to Heat and Cold Stress
Clinical Trials: Overview
Trial and Error and Algorithm
Random Error

